トランスフェクション試薬及び装置の世界市場...市場調査レポートについてご紹介

1 Introduction (Page No. – 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 24)
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.3 Key Data From Secondary Sources
2.1.3.1 Primary Research
2.1.3.2 Key Industry Insights
2.1.4 Key Data From Primary Sources
2.1.5 Key Insights From Primary Sources
2.1.6 Market Size Estimation Methodology
2.1.7 Market Forecast Methodology
2.1.8 Market Data Validation and Triangulation
2.1.9 Assumptions

3 Executive Summary (Page No. – 34)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 39)
4.1 Global Transfection Reagents and Equipment Market
4.2 Transfection Reagents and Equipment Market, By Application and Region
4.3 Transfection Reagents and Equipment Market, By Product (2015 vs 2020)

5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Growing Research Activities in Cell Science
5.3.1.2 Technological Advancements in Transfection Instruments and Reagents
5.3.1.3 Rising Incidence of Cancer Worldwide
5.3.1.4 Global Alliances Among Leading Research Institutes to Trigger Drug Discovery
5.3.2 Restraints
5.3.2.1 High Reliability on Grants Might Restrict Growth
5.3.2.2 Selective Effectiveness of Transfection Reagents
5.3.3 Opportunities
5.3.3.1 Large-Scale Transfections
5.3.3.2 Rising Demand for Protein Therapeutics
5.3.3.3 Asian Market Presents High-Growth Opportunities
5.4 Challenges
5.4.1 Transfection in Hard-To-Transfect Cells

6 Transfection Reagents and Equipment Market, By Product (Page No. – 55)
6.1 Introduction
6.2 Reagents
6.3 Equipment/Instruments

7 Transfection Reagents and Equipment Market, By Method (Page No. – 60)
7.1 Introduction
7.2 Biochemical Methods
7.2.1 Introduction
7.2.2 Calcium Phosphate
7.2.2.1 Advantages
7.2.2.2 Disadvantages
7.2.3 Lipofection
7.2.3.1 Advantages
7.2.3.2 Disadvantages
7.2.4 Deae-Dextran
7.2.4.1 Advantages
7.2.4.2 Disadvantages
7.2.5 Dendrimers
7.2.5.1 Advantages
7.2.5.2 Disadvantages
7.3 Physical
7.3.1 Introduction
7.3.2 Electroporation
7.3.2.1 Advantages
7.3.2.2 Disadvantages
7.3.3 Nucleofection
7.3.3.1 Advantages
7.3.3.2 Disadvantages
7.3.4 Other Methods
7.3.4.1 Sonoporation
7.3.4.2 Gene Gun
7.3.4.2.1 Advantages
7.3.4.2.2 Disadvantages
7.3.4.3 Magnetofection
7.3.4.3.1 Advantages
7.3.4.3.2 Disadvantages
7.3.4.4 Optoinjection
7.3.4.4.1 Advantages
7.3.4.4.2 Disadvantages
7.4 Viral Methods
7.4.1 Introduction
7.4.1.1 Adenoviruses
7.4.1.2 Retroviruses
7.4.1.3 Adenoassociated Viruses
7.4.2 Advantages
7.4.3 Limitations

8 Transfection Reagents and Equipment Market, By Application (Page No. – 79)
8.1 Introduction
8.2 Biomedical Research
8.2.1 Gene Expression Studies
8.2.2 Cancer Research
8.2.3 Transgenic Models
8.3 Protein Production
8.4 Therapeutic Delivery

9 Global Transfection Reagents and Equipment Market, By Region (Page No. – 90)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Increase in Bio-Based Drug Research
9.2.1.2 Growing Demand for Protein-Based Therapeutics Triggers the Growth of U.S. Market
9.2.1.3 Growing Funding for Biotechnology and for Development of Protein Based Biologics
9.2.2 Canada
9.2.2.1 Government Support for Development of Protein Drugs is Expected to Drive the Market for Transfection Technologies
9.2.2.2 Increasing Investments By the Canadian Government on Regenerative Medicine to Spur Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Advances in the Biotechnological & Research Sectors
9.3.1.2 Collaboration Among the Bio-Pharmaceutical and Biotechnology Companies for Development of New Vaccines is Likely the Spur the Market Growth
9.3.2 U.K.
9.3.2.1 Strong Biotechnology Industry
9.3.2.2 Increase in R&D Investments
9.3.3 France
9.3.3.1 Strong Biotechnology Industry in France
9.3.4 Rest of Europe (RoE)
9.3.4.1 Growing Biotechnology Industry in Italy and Spain
9.3.4.2 Investments and Funding for Life Sciences to Bolster the Transfection Reagents and Equipment Market
9.4 Asia-Pacific
9.4.1 Japan
9.4.1.1 Rise in Biomedical Research in Japan
9.4.2 China
9.4.2.1 Increasing Government and Private Sector Investments in China’s Life Sciences Market
9.4.3 India
9.4.3.1 Booming Pharmaceutical Industry and Funding for Biotechnology
9.4.3.2 Development of Bio-Clusters in India
9.4.4 Pacific Countries
9.4.4.1 Favourable Regulatory Changes to Increase the Market in New Zealand and Australia
9.4.4.2 Federal Collaborations in Australia
9.4.5 Rest of Asia
9.4.5.1 Rising Pharmaceutical and Biotechnology R&D Activities in Korea
9.4.5.2 Government Support for Strong Academic and Commercial R&D Activities in Taiwan
9.5 Rest of the Word (RoW)
9.5.1 Latin America
9.5.1.1 Increasing Investment in Brazil and Mexico
9.5.2 Middle East and Africa

10 Competitive Landscape (Page No. – 156)
10.1 Overview
10.2 Market Share Analysis, Transfection Reagents and Equipment Market (2014)
10.3 Competitive Situation and Trends
10.4 Agreements,Partnerships,Collaborations & Strategic Alliances
10.5 New Product Launches
10.6 Expansions
10.7 Acquisitions
10.8 Others

11 Company Profiles (Page No. – 173)
11.1 Introduction
11.2 Thermo Fisher Scientific, Inc. (Life Technologies)
11.2.1 Business Review
11.2.2 Financials
11.2.3 Product Offerings
11.2.4 Recent Developments
11.2.5 MnM View
11.2.5.1 Strategic Analysis
11.3 Promega Corporation
11.3.1 Business Overview
11.3.2 Financials
11.3.3 Product Offerings
11.3.4 Recent Developments
11.3.5 MnM View
11.3.5.1 Strategic Analysis
11.4 Qiagen N.V.
11.4.1 Business Overview
11.4.2 Financials
11.4.3 Product Portfolio
11.4.4 Recent Developments
11.4.5 MnM View
11.4.5.1 Strategic Analysis Research & Development and Innovation Focus Strategic Acquisitions
11.5 Polyplus Transfection SA
11.5.1 Business Review
11.5.2 Financials
11.5.3 Product Portfolio
11.5.4 Recent Developments
11.5.5 MnM View
11.5.5.1 Strategic Analysis
11.6 Roche
11.6.1 Business Review
11.6.2 Financials
11.6.3 Product Portfolio
11.6.4 Recent Developments
11.6.5 MnM View
11.6.5.1 Strategic Analysis
11.7 Bio–Rad Laboratories Inc.
11.7.1 Business Review
11.7.2 Financials
11.7.3 Product Portfolio
11.7.4 Recent Developments
11.7.5 MnM View
11.7.5.1 Strategic Analysis
11.8 Lonza Group
11.8.1 Business Review
11.8.2 Financials
11.8.3 Product Portfolio
11.8.4 Recent Developments
11.9 Sigma- Aldrich Corporation
11.9.1 Business Overview
11.9.2 Financials
11.9.3 Product Portfolio
11.9.4 Recent Developments
11.10 Mirus Bio LLC.
11.10.1 Business Review
11.10.2 Financials
11.10.3 Product Portfolio
11.10.4 Recent Developments
11.11 Maxcyte, Inc.
11.11.1 Business Review
11.11.2 Financials
11.11.3 Product Portfolio
11.11.4 Recent Developments

12 Appendix (Page No. – 214)
12.1 Discussion Guide
12.2 Company Developments (2012-2015)
12.2.1 Thermo Fisher Scientific, Inc.
12.2.2 Promega Corporation
12.2.3 Qiagen N.V.
12.2.4 Sigma- Aldrich Corporation
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports